AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2024
Feb 26, 2024
34129_dirs_2024-02-26_acaadc83-f106-47f0-818d-7c4af21cb821.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-02-22
Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-22 | Common Stock | M | 26250 | — | Acquired | 35145 | Direct |
| 2024-02-22 | Common Stock | F | 10126 | $17.11 | Disposed | 25019 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | Restricted Stock Unit | $0 | M | 26250 | Disposed | Common Stock (26250) | Direct |
Footnotes
F1: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18